mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
4e-08 |
mRNA |
SNX-2112 |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
9e-08 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
3e-07 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
4e-07 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
5e-07 |
mRNA |
Ki8751 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
2e-06 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-06 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-06 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
4e-06 |
mRNA |
FK866 |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
5e-06 |